Biomarkers – Multimedia

The metabolites produced by a cell, tissue or organism represent the endpoint of the omics process. Download this infographic to learn more about metabolomics and how it is studied.

Formalin-fixed, paraffin-embedded (FFPE) tissue is a valuable resource in the retrospective proteomic analysis of clinical and non-clinical samples.

While depleting abundant proteins can facilitate the detection of low-concentration biomarkers, such methods can be labor-intensive, costly and can result in sample loss. Discover how parallel accumulation, serial elution and fragmentation (PASEF) can support researchers to achieve accurate large-scale plasma proteomics.

A new study identifies a set of biomarkers that could help clinicians to predict whether pancreatic cysts will remain benign or develop into cancer.

While most protein assays excel in one or two areas, the SomaScan Assay is the first and only platform that can measure 7,000 proteins from a 55-µL sample – covering more biological pathways than any other proteomic assay.

Developed for performance in human serum and plasma, the SomaScan Assay v4.1 can measure approximately 7,000 unique human protein analytes in small volumes of biological samples.

The Ella instrument by Bio-Techne automates every step of the immunoassay workflow, helping to minimize user error while ensuring highly precise and reproducible results.

Speaking at ‘Advances in Proteomics & Metabolomics’ 2022, Erik Johnson from Emory University, presented their talk on proteomics in Alzheimer’s disease.

Spatial biology requires highly validated reagents to accurately resolve proteins in the tissue microenvironment. Although immunofluorescence techniques are some of the most commonly used research tools, there are no universally accepted guidelines for antibody validation.

Speaking at The Landscape of Cancer Research 2022 online symposium, Sofia Lourenco of Cancer Research Horizons delivered her talk on the challenges facing the future of cancer immunotherapies.